268 related articles for article (PubMed ID: 37780616)
1. Treatment of hypothalamic obesity in people with hypothalamic injury: new drugs are on the horizon.
Roth CL; Zenno A
Front Endocrinol (Lausanne); 2023; 14():1256514. PubMed ID: 37780616
[TBL] [Abstract][Full Text] [Related]
2. Acquired hypothalamic obesity: A clinical overview and update.
Roth CL; McCormack SE
Diabetes Obes Metab; 2024 Apr; 26 Suppl 2():34-45. PubMed ID: 38450938
[TBL] [Abstract][Full Text] [Related]
3. Approach to the Patient With Hypothalamic Obesity.
Shoemaker AH; Tamaroff J
J Clin Endocrinol Metab; 2023 Apr; 108(5):1236-1242. PubMed ID: 36413492
[TBL] [Abstract][Full Text] [Related]
4. Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity.
van Santen HM; Schouten-Meeteren AY; Serlie M; Meijneke RW; van Trotsenburg AS; Verberne H; Holleman F; Fliers E
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):53-7. PubMed ID: 25514327
[TBL] [Abstract][Full Text] [Related]
5. Management of Hypothalamic Obesity.
Müller HL
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):533-552. PubMed ID: 32741487
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review.
van Iersel L; Brokke KE; Adan RAH; Bulthuis LCM; van den Akker ELT; van Santen HM
Endocr Rev; 2019 Feb; 40(1):193-235. PubMed ID: 30247642
[TBL] [Abstract][Full Text] [Related]
7. Oxytocin and Naltrexone Successfully Treat Hypothalamic Obesity in a Boy Post-Craniopharyngioma Resection.
Hsu EA; Miller JL; Perez FA; Roth CL
J Clin Endocrinol Metab; 2018 Feb; 103(2):370-375. PubMed ID: 29220529
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic obesity in children.
Bereket A; Kiess W; Lustig RH; Muller HL; Goldstone AP; Weiss R; Yavuz Y; Hochberg Z
Obes Rev; 2012 Sep; 13(9):780-98. PubMed ID: 22577758
[TBL] [Abstract][Full Text] [Related]
9. Postoperative hypothalamic damage predicts postoperative weight gain in patients with adult-onset craniopharyngioma.
Wu J; Fu J; Huang ZJ; Xie SH; Tang B; Wu X; Tong ZG; Wu BW; Pan CB; Yang YQ; Ding H; Li SY; Qi JL; Hong T
Obesity (Silver Spring); 2022 Jul; 30(7):1357-1369. PubMed ID: 35707874
[TBL] [Abstract][Full Text] [Related]
10. Hypothalamic obesity.
Babcock Gilbert S; Roth LW
Minerva Endocrinol; 2015 Mar; 40(1):61-70. PubMed ID: 25370939
[TBL] [Abstract][Full Text] [Related]
11. GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases.
Zoicas F; Droste M; Mayr B; Buchfelder M; Schöfl C
Eur J Endocrinol; 2013 May; 168(5):699-706. PubMed ID: 23392214
[TBL] [Abstract][Full Text] [Related]
12. Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury.
Ismail D; O'Connell MA; Zacharin MR
J Pediatr Endocrinol Metab; 2006 Feb; 19(2):129-34. PubMed ID: 16562585
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamic Obesity: Prologue and Promise.
Abuzzahab MJ; Roth CL; Shoemaker AH
Horm Res Paediatr; 2019; 91(2):128-136. PubMed ID: 30884480
[TBL] [Abstract][Full Text] [Related]
14. Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity.
Roth CL; Eslamy H; Werny D; Elfers C; Shaffer ML; Pihoker C; Ojemann J; Dobyns WB
Obesity (Silver Spring); 2015 Jun; 23(6):1226-33. PubMed ID: 25884561
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Acquired Hypothalamic Obesity: Now and the Future.
Dimitri P
Front Endocrinol (Lausanne); 2022; 13():846880. PubMed ID: 35464063
[TBL] [Abstract][Full Text] [Related]
16. Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index.
Trivin C; Busiah K; Mahlaoui N; Recasens C; Souberbielle JC; Zerah M; Sainte-Rose C; Brauner R
BMC Pediatr; 2009 Apr; 9():24. PubMed ID: 19341477
[TBL] [Abstract][Full Text] [Related]
17. Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma.
Holmer H; Pozarek G; Wirfält E; Popovic V; Ekman B; Björk J; Erfurth EM
J Clin Endocrinol Metab; 2010 Dec; 95(12):5395-402. PubMed ID: 20826582
[TBL] [Abstract][Full Text] [Related]
18. A novel rodent model that mimics the metabolic sequelae of obese craniopharyngioma patients.
Roth CL; Blevins JE; Ralston M; Elfers C; Ogimoto K; Kaiyala KJ; Morton GJ
Pediatr Res; 2011 Mar; 69(3):230-6. PubMed ID: 21372758
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Hypothalamic Obesity with Dextroamphetamine: A Case Series.
Denzer C; Denzer F; Lennerz BS; Vollbach H; Lustig RH; Wabitsch M
Obes Facts; 2019; 12(1):91-102. PubMed ID: 30844799
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: a matched case-control study with 2 years of follow-up.
Wijnen M; Olsson DS; van den Heuvel-Eibrink MM; Wallenius V; Janssen JA; Delhanty PJ; van der Lely AJ; Johannsson G; Neggers SJ
Int J Obes (Lond); 2017 Feb; 41(2):210-216. PubMed ID: 27795552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
